SOTERA HEALTH CO (SHC)

US83601L1026 - Common Stock

10.91  -0.36 (-3.19%)

After market: 10.91 0 (0%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to SHC. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 17.24. This target is 58% above the current price.
SHC was analyzed by 11 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about SHC.
In the previous month the buy percentage consensus was at a similar level.
SHC was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 10.9114.1416.3217.2421.00 - 29.61% 49.59% 58.00% 92.48%
Up and Down Grades
Date Firm Action Rating
2024-04-10 Barclays Maintains Overweight -> Overweight
2024-04-03 Citigroup Upgrade Neutral -> Buy
2024-03-25 Jefferies Upgrade Hold -> Buy
2024-03-11 RBC Capital Reiterate Outperform -> Outperform
2024-03-04 RBC Capital Reiterate Outperform -> Outperform
2024-02-28 Barclays Maintains Overweight -> Overweight
2024-02-06 Keybanc Initiate Sector Weight
2024-01-25 Barclays Maintains Overweight -> Overweight
2023-11-02 RBC Capital Maintains Outperform -> Outperform
2023-11-02 Barclays Maintains Overweight -> Overweight
2023-08-04 Keybanc Maintains Overweight -> Overweight
2023-08-04 RBC Capital Maintains Outperform -> Outperform
2023-06-26 Keybanc Upgrade Sector Weight -> Overweight
2023-06-22 Keybanc Maintains Sector Weight
2023-05-04 RBC Capital Maintains Outperform
2023-05-04 Barclays Maintains Overweight
2023-04-04 Barclays Maintains Overweight
2023-03-01 RBC Capital Maintains Outperform
2023-01-23 JP Morgan Upgrade Underweight -> Neutral
2023-01-11 Wolfe Research Upgrade Peer Perform -> Outperform
2023-01-11 Barclays Upgrade Underweight -> Overweight
2022-11-23 Goldman Sachs Maintains Neutral
2022-11-16 Barclays Downgrade Equal-Weight -> Underweight
2022-11-15 Barclays Downgrade Equal-Weight -> Underweight
2022-11-03 RBC Capital Maintains Outperform
2022-11-03 JP Morgan Maintains Underweight
2022-10-06 Barclays Maintains Equal-Weight
2022-10-05 Citigroup Downgrade Buy -> Neutral
2022-09-26 Keybanc Downgrade Overweight -> Sector Weight
2022-09-21 JP Morgan Downgrade Overweight -> Underweight